CytomX Therapeutics
CTMX
CTMX
88 hedge funds and large institutions have $97.1M invested in CytomX Therapeutics in 2024 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 19 increasing their positions, 24 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
16.94% more ownership
Funds ownership: 48.85% → 65.79% (+17%)
21% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 24
Holders
88
Holding in Top 10
–
Calls
$353K
Puts
$10K
Top Buyers
| 1 | +$7.73M | |
| 2 | +$4.36M | |
| 3 | +$3.48M | |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
+$2.78M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.96M |
Top Sellers
| 1 | -$833K | |
| 2 | -$719K | |
| 3 | -$678K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$570K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$472K |